The Effect of Blood on the PC Ratio During Pregnancy

Sponsor
Marshall University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05434845
Collaborator
University at Buffalo (Other)
20
4
6

Study Details

Study Description

Brief Summary

This study will examine the effect if blood on the the protein to creatine (PC) ratio in pregnant patients by adding blood to urine samples.

Condition or Disease Intervention/Treatment Phase
  • Other: Blood draw
N/A

Detailed Description

The Purpose of the Research:

The purpose of this study is to examine the effect of blood on the protein to creatine (PC) ratio in pregnant patients.

The Scientific or Scholarly Rationale:

The PC ratio is used to diagnosis proteinuria in pregnancy. It is thought that blood in the urine will cause the PC ratio to be elevated but there are no current studies to prove this hypothesis.

The Procedures to be Performed:

Upon presentation to the Labor and Delivery Triage or the Antepartum Unit, patients will be enrolled in the study. Urine collection that is not needed for medical workup will be collected and saved, and an extra 8 mLs of blood will be drawn during routine lab collection by phlebotomy team. Additional lab costs will be covered by Marshall Obstetrics & Gynecology.

Lab protocol: Divide urine into 4 different specimen cups with 20 mLs of urine each to measure urinalysis (UA) and PC ratio:

  1. UA and PC ratio on original sample

  2. UA and PC ratio with 1 mL of whole blood added

  3. UA and PC ratio with 2 mL of whole blood added

  4. UA and PC ratio with 5 mL of whole blood added

Subjects medical records will be reviewed for past obstetrical history after consent to be in the study.

The Risks and Potential Benefits of the Research:

Risks: 8 mLs of additional maternal blood will be drawn for study purposes. Possible risks could include pain, bleeding, fainting, bruising, infection, or hematoma (blood clot under the skin) at the injection site. Please note that routine blood would be drawn regardless of study enrollment.

Benefits: Our hypothesis is that the PC ratio will be elevated by contamination with blood. It is unknown if this hypothesis is correct.

Complete Inclusion/Exclusion Criteria (may be submitted separately if extensive):

Inclusion criteria includes patients presenting to Labor and Delivery Triage or Antepartum Unit at Cabell Huntington Hospital between the ages of 18 and approximately 45 years and gestational age of >20 weeks.

Exclusion criteria includes pre-existing proteinuria (excess protein in the urine) or hematuria (blood in the urine).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Divide urine into 4 different specimen cups with 20 mLs of urine each to measure urinalysis (UA) and PC ratio: UA and PC ratio on original sample UA and PC ratio with 1 mL of whole blood added UA and PC ratio with 2 mL of whole blood added UA and PC ratio with 5 mL of whole blood addedDivide urine into 4 different specimen cups with 20 mLs of urine each to measure urinalysis (UA) and PC ratio:UA and PC ratio on original sample UA and PC ratio with 1 mL of whole blood added UA and PC ratio with 2 mL of whole blood added UA and PC ratio with 5 mL of whole blood added
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
The Effect of Blood on the Protein to Creatine Ratio During Pregnancy
Anticipated Study Start Date :
Jun 19, 2022
Anticipated Primary Completion Date :
Dec 19, 2022
Anticipated Study Completion Date :
Dec 19, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: UA and PC ratio on original sample

Original urine sample

Active Comparator: UA and PC ratio with 1 mL of whole blood added

1 mL of whole blood added to 20 mLs of urine

Other: Blood draw
An additional 8 mL of blood will be drawn during routine lab collection

Active Comparator: UA and PC ratio with 2 mL of whole blood added

2 mL of whole blood added to 20 mLs of urine

Other: Blood draw
An additional 8 mL of blood will be drawn during routine lab collection

Active Comparator: UA and PC ratio with 5 mL of whole blood added

5 mL of whole blood added to 20 mLs of urine

Other: Blood draw
An additional 8 mL of blood will be drawn during routine lab collection

Outcome Measures

Primary Outcome Measures

  1. To measure the PC ratio after whole blood has been serially added [6 months]

    The PC ratio is used to diagnose proteinuria in pregnancy. Our goal is to determine if blood causes the PC ratio to be elevated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Labor and Delivery Triage or Antepartum Unit at Cabell Huntington Hospital between the ages of 18 and approximately 45 years and gestational age of >20 weeks
Exclusion Criteria:
  • pre-existing proteinuria (excess protein in the urine) or hematuria (blood in the urine)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Marshall University
  • University at Buffalo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jesse Cottrell, Assistant Professor, Marshall University
ClinicalTrials.gov Identifier:
NCT05434845
Other Study ID Numbers:
  • 1912480
First Posted:
Jun 28, 2022
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022